NZ763906B2 - An embolisation device - Google Patents
An embolisation deviceInfo
- Publication number
- NZ763906B2 NZ763906B2 NZ763906A NZ76390615A NZ763906B2 NZ 763906 B2 NZ763906 B2 NZ 763906B2 NZ 763906 A NZ763906 A NZ 763906A NZ 76390615 A NZ76390615 A NZ 76390615A NZ 763906 B2 NZ763906 B2 NZ 763906B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- segment
- proximal
- stem
- distal
- bristles
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 12
- 238000005755 formation reaction Methods 0.000 claims abstract description 12
- 230000001737 promoting Effects 0.000 claims abstract description 5
- 239000012528 membrane Substances 0.000 claims description 158
- 239000003550 marker Substances 0.000 claims description 37
- 101700030310 FUS Proteins 0.000 claims 1
- 101700014034 Lcn3 Proteins 0.000 claims 1
- 101700062818 NP Proteins 0.000 claims 1
- 101710026336 S5 Proteins 0.000 claims 1
- 101710023234 Segment 5 Proteins 0.000 claims 1
- ASCUXPQGEXGEMJ-GPLGTHOPSA-N [(2R,3S,4S,5R,6S)-3,4,5-triacetyloxy-6-[[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(4-methylanilino)oxan-2-yl]methoxy]oxan-2-yl]methyl acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H](COC(=O)C)O[C@@H]1OC[C@@H]1[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](NC=2C=CC(C)=CC=2)O1 ASCUXPQGEXGEMJ-GPLGTHOPSA-N 0.000 claims 1
- 239000007943 implant Substances 0.000 description 57
- 210000003462 Veins Anatomy 0.000 description 27
- 210000001367 Arteries Anatomy 0.000 description 24
- 239000000463 material Substances 0.000 description 23
- 206010002329 Aneurysm Diseases 0.000 description 13
- 238000011068 load Methods 0.000 description 11
- 238000004873 anchoring Methods 0.000 description 10
- 241001157812 Alternaria brassicicola Species 0.000 description 7
- 210000002216 Heart Anatomy 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 230000001965 increased Effects 0.000 description 7
- 230000002792 vascular Effects 0.000 description 7
- 150000002500 ions Chemical class 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000005012 migration Effects 0.000 description 6
- 239000010409 thin film Substances 0.000 description 6
- 210000003240 Portal Vein Anatomy 0.000 description 5
- JOYRKODLDBILNP-UHFFFAOYSA-N ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229910001000 nickel titanium Inorganic materials 0.000 description 5
- 239000004810 polytetrafluoroethylene Substances 0.000 description 5
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 5
- 229920002635 polyurethane Polymers 0.000 description 5
- 239000004814 polyurethane Substances 0.000 description 5
- 239000004721 Polyphenylene oxide Substances 0.000 description 4
- 230000002440 hepatic Effects 0.000 description 4
- 229920000570 polyether Polymers 0.000 description 4
- 230000002829 reduced Effects 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 210000004369 Blood Anatomy 0.000 description 3
- 210000003090 Iliac Artery Anatomy 0.000 description 3
- 210000003484 anatomy Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 238000002697 interventional radiology Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 206010064684 Device dislocation Diseases 0.000 description 2
- 206010018852 Haematoma Diseases 0.000 description 2
- 210000004072 Lung Anatomy 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 210000002563 Splenic Artery Anatomy 0.000 description 2
- 241001459538 Ute Species 0.000 description 2
- 230000000903 blocking Effects 0.000 description 2
- 229910000701 elgiloys (Co-Cr-Ni Alloy) Inorganic materials 0.000 description 2
- 230000003073 embolic Effects 0.000 description 2
- 230000002708 enhancing Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000002685 pulmonary Effects 0.000 description 2
- 239000003229 sclerosing agent Substances 0.000 description 2
- 238000004513 sizing Methods 0.000 description 2
- 201000004822 varicocele Diseases 0.000 description 2
- 208000002223 Abdominal Aortic Aneurysm Diseases 0.000 description 1
- 210000004204 Blood Vessels Anatomy 0.000 description 1
- 208000001750 Endoleak Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010018987 Haemorrhage Diseases 0.000 description 1
- 210000002837 Heart Atria Anatomy 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000002287 Hemorrhoids Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- 210000003141 Lower Extremity Anatomy 0.000 description 1
- 229910000990 Ni alloy Inorganic materials 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 210000003101 Oviducts Anatomy 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 210000001147 Pulmonary Artery Anatomy 0.000 description 1
- 210000002796 Renal Veins Anatomy 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive Effects 0.000 description 1
- 201000001182 arteriovenous malformation Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000000271 cardiovascular Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229910052803 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 230000001010 compromised Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 230000001419 dependent Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000002496 gastric Effects 0.000 description 1
- 230000002710 gonadal Effects 0.000 description 1
- 230000000004 hemodynamic Effects 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003447 ipsilateral Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organs Anatomy 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920002530 poly[4-(4-benzoylphenoxy)phenol] polymer Polymers 0.000 description 1
- 229920001692 polycarbonate urethane Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005597 polymer membrane Polymers 0.000 description 1
- 230000000717 retained Effects 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 230000003393 splenic Effects 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 201000010874 syndrome Diseases 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- 230000002381 testicular Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001732 thrombotic Effects 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 238000007631 vascular surgery Methods 0.000 description 1
- 201000002282 venous insufficiency Diseases 0.000 description 1
- 230000002618 waking Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/12031—Type of occlusion complete occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/1215—Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12163—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a string of elements connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12177—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure comprising additional materials, e.g. thrombogenic, having filaments, having fibers or being coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00526—Methods of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00982—General structural features
- A61B2017/00995—General structural features having a thin film
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
- A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
- A61B2017/12095—Threaded connection
Abstract
There is provided herein an embolisation device for promoting clot formation in a lumen. The embolisation device comprises more than two segments, including at least a proximal segment and a distal segment. Each segment comprises a stem and a plurality of flexible bristles extending outwardly from the stem. The bristles have a contracted delivery configuration and a deployed configuration in which the bristles extend generally radially outwardly from the stem to anchor the device in a lumen. A proximal connection between the proximal segment and a segment adjacent to the proximal segment is relatively stiff. the stem. The bristles have a contracted delivery configuration and a deployed configuration in which the bristles extend generally radially outwardly from the stem to anchor the device in a lumen. A proximal connection between the proximal segment and a segment adjacent to the proximal segment is relatively stiff.
Description
AN EMBOLISATION DEVICE
RELATED APPLICATIONS
The present application is a divisional application of New Zealand patent application no. 755781,
which is a divisional application of New Zealand application no. 746276, which is a divisional
application of New Zealand application no. 729857, which is a national phase entry of PCT application
no. , which claims priority from the EP application nos. 07.7, 15151922.0
and 92.0, the contents of each of which are orated herein by reference.
INTRODUCTION
This invention relates to an embolisation device.
Migration of conventional embolisation coils occurs 4-14% of transcatheter embolisations [1,2].
Non-target embolisation is an outcome of coils migration, the impact of which depends on the
final location of the coils. In the venous system, the consequences can be catastrophic with
ture indicating that coils can e into the renal vein, right atrium of the heart, lung
(pulmonary artery). Percutaneous retrieval of the coils is technically very challenging and
frequently cannot be attempted as the coils are often entrapped within the organs and tissue.
Coil migration occurs for various reasons:
• cal error: release of a coil or coil pack too distal or proximal to an adjoining larger
vessel or plexus [3,4]
• High blood flow areas can cause the coil to migrate.
• Coil: vessel mismatch. The coils are undersized, hence will not injure the vessel wall, will
not induce thrombosis, and are likely to migrate. Or the coils are oversized and will act
like a guide-wire and pass r ly into the vessel [5,6].
• Vessel dilation: coil ion can occur due to a disparity in the size of coils and dilated
vessels, which can change in their diameters depending on vessel hemodynamics [7].
• Coils impart a very low radial (anchor) force on the lumen, once a clot forms within the
coil, blood flow can force it to migrate.
The profile of the embolisation device and delivery system is a critical s factor in
successfully accessing target embolisation locations e.g. the iliac arteries are frequently tortuous
in the presence of abdominal aortic aneurysms [5]. To combat this issue today, microcatheters are
18517168_1 (GHMatters) P42741NZ04
often employed in difficult or tortuous anatomy where use of standard catheters may induce spasm
and lead to a failed embolisation procedure [5]. Additionally different stages in a ure may
require catheters with different mechanical properties e.g. accessing a visceral vessel, particularly
in the presence of diseased or tortuous es, may require a catheter with a high degree of
stiffness and torque control. In general, the lower the profile of the device and delivery system,
the greater the accessibility of the device into tortuous and higher order vessels. A lower profile
device reduces the diameter of catheter required for delivery and lowers the risks of access site
ions, hematomas and lumen spasm.
Dependent on the clinical ation of the device, le anchor forces may be required to
prevent migration of the prosthesis e.g. arterial and venous applications have variable blood flow
rates and forces. This in turn, will lead to a compromise in terms of e since in order to anchor
the device stiffer, and consequently larger elements may be required. For example in the case of a
bristle device larger diameter fibres may be required.
The technique generally used to embolise vessels today is to insert a metallic scaffold (coil, plug)
into the target vessel, to cause a thrombus that adheres to the scaffold, relying on the thrombus to
induce blood cessation and eventually occlude the vessel. In general, available embolisation
logy does not interfere with or interact with blood flow densely enough across the vessel
cross section to induce rapid, permanent vessel occlusion.
Using technology available today, the physician will often have to prolong a specific duration of
time for the technology to induce ion. In one approach the ian inserts coils and then
waits 20 minutes for the coils to expand and cause vessel occlusion [8].
The restoration of the lumen of a blood vessel following thrombotic occlusion by restoration of
the l or by the formation of new channels, is termed recanalisation. Recanalisation can
occur due to, coil migration, fragmentation of the sation material, and formation of a new
vessel lumen that circumvents the occlusion [6]. Recanalization rates vary by procedure and
c agent, ranging from 10% in portal vein embolisation to 15% for pulmonary arteriovenous
malformations to 30% for splenic artery embolisation [9,10,11].
18517168_1 (GHMatters) P42741NZ04
SUMMARY
An aspect of the t invention provides an embolisation device for ing clot formation
in a lumen, comprising more than two segments, including at least a proximal segment and a distal
segment, each segment sing a stem and a plurality of flexible bristles extending outwardly
from the stem, the bristles having a contracted delivery configuration and a deployed configuration
in which the bristles extend generally radially outwardly from the stem to anchor the device in a
lumen; wherein a proximal connection between the al t and a segment nt to
the proximal segment is vely stiff.
According to embodiments, in the deployed configuration, bristles of one segment extend partially
in a first longitudinal direction and the bristles of another segment extend partially in a second
longitudinal direction which is opposite to the first longitudinal direction.
According to embodiments, the device includes a flow restrictor, optionally wherein the flow
restrictor comprises a membrane. The flow restrictor may have a contracted delivery configuration
and an expanded ed configuration. According to embodiments, the flow restrictor is located
longitudinally within the bristles of the proximal segment or the distal t.
According to embodiments, the device further comprises a ity of further segments between
the distal segment and the proximal segment. According to embodiments, connections between at
least some of the further segments comprise a hinge to facilitate relative movement between the
segments. A connection n at least some of the ts intermediate the proximal segment
and the distal segment is relatively rigid.
According to embodiments, a proximal end of the device is adapted for releasable connection with
a delivery means such as a delivery wire or tube.
According to embodiments, the device further comprises a proximal connector for releasable
tion to a delivery element. The proximal connector may comprise a connector stem. The
connector stem may be coupled to the stem of the proximal segment. According to embodiments,
the connector stem is hingedly mounted to the stem of the proximal segment. According to
embodiments, the connector stem has a mounting e for engagement with a mounting feature
18517168_1 (GHMatters) P42741NZ04
of the delivery element. According to embodiments, the mounting feature of the connector stem
comprises a screw thread.
According to embodiments, the proximal connection incorporates or comprises a aque
marker such as marker band.
According to ments, the device further comprises a distal radiopaque marker which is
located on a distal side adjacent to a most distal segment. The device may comprise a proximal
aque marker located on a al side adjacent to a most proximal marker. The device
may comprise radiopaque marker intermediate the proximal segment and the distal segment.
There is further described herein an embolization device, comprising: a proximal segment; a distal
segment, each of the proximal and distal segments including a stem, and a plurality of anchoring
bristles extending outwardly from the stem, wherein the distal segments includes more bristles
than the proximal t; and a flow restricting membrane.
There is further described herein an embolization device, comprising: a proximal segment; a distal
segment, each of the proximal and distal segments including a stem, and a plurality of anchoring
bristles extending outwardly from the stem; and a flow restricting membrane located on the
proximal segment.
There is further described herein an zation device, comprising: a al segment; a distal
segment, each of the proximal and distal ts including a stem, and a plurality of anchoring
bristles extending outwardly from the stem; and a flow cting membrane located longitudinally
within the bristles of one of said segments.
There is further described herein an embolization device, comprising: a proximal segment; a distal
segment, each of the al and distal segments including a stem, and a plurality of ing
bristles extending outwardly and circumferentially from the stem; and a flow restricting membrane
extending from the stem and having an outer dimension less than an outer dimension of the
plurality of anchoring bristles of the proximal segment.
18517168_1 (GHMatters) P42741NZ04
There is further described herein an embolization system, comprising: a delivery catheter; and an
embolization device having a loaded configuration when the device is loaded in the delivery
catheter, and a delivered configuration when the device is urged out from the catheter, the
embolization device further ing a proximal segment; a distal segment, each of the proximal
and distal segments including a stem, and a plurality of anchoring bristles extending dly
from the stem, the es of the proximal segment being deflected in a first direction in the loaded
uration, and the bristles of the distal segment being deflected in a second direction in the
loaded configuration, the first direction being opposite the second direction; and a flow restricting
membrane ted in the first direction in the loaded configuration.
There is further described herein an embolisation device for promoting clot formation in a lumen
comprising at least two ts, each segment comprising a stem and a plurality of flexible
bristles extending outwardly from the stem, the bristles having a contracted delivery configuration
and a deployed uration in which the bristles extend generally radially outwardly from the
stem to anchor the device in a lumen wherein, in the deployed configuration bristles of one segment
extend lly in a first longitudinal direction and the bristles of r segment extend partially
in a second longitudinal direction which is opposite to the first longitudinal direction.
In one embodiment in the contracted delivery configuration the bristles of one segment extend
partially in a first longitudinal direction and the bristles of another segment extend partially in a
second longitudinal direction which is opposite to the first longitudinal direction.
In one case the device includes a flow restrictor having a cted delivery configuration and an
expanded deployed configuration. The flow restrictor may be d adjacent to a proximal end
of the device. The flow restrictor may be located within or adjacent to the most proximal segment.
Alternatively or additionally the flow restrictor is located adjacent to the distal end of the device.
The flow restrictor may be d within or adjacent to the most distal segment.
In one embodiment the flow restrictor comprises a membrane.
In one case a flow restricting membrane is located udinally within the bristles of the proximal
t and/or the distal segment. The flow cting membrane may extend from the stem.
The flow restricting membrane may have an outer dimension which is less than an outer dimension
18517168_1 (GHMatters) P42741NZ04
of the plurality of anchoring bristles. The flow restricting membrane may be connected to the
stem. In some cases the flow restricting membrane may have a central hole. The central hole in
the membrane is preferably smaller than the stem on which it is mounted. The central hole in the
membrane may have a diameter which is smaller than the diameter of the stem.
The central hole may adapt its shape and dimension at least in part to the shape and dimensions of
a cross section of the stem. The central hole may be stretched during mounting in order to fit the
stem.
In one case there is an interference fit between the central hole and the stem.
In one case the bristles in an unconstrained uration extend to a radial extent which is greater
than the radial extent of the membrane in the unconstrained configuration. In the constrained
configuration, the membrane may have a udinal extent. In the deployed configuration, the
ne may have a conical or cup-like shape.
In one embodiment the flow restrictor is of a flexible material. The flow ctor may be of a
polymeric material. The flow restrictor may be of an elastomeric material. The flow restrictor
may comprise a film.
In one embodiment the flow restrictor comprises a shape memory material such as Nitinol.
In one case the device comprises connectors between the segments. A proximal tion
between the most proximal segment and the segment adjacent to the proximal segment may be
relatively stiff. The proximal connection may incorporate or comprise a marker band.
In one ment the embolization device comprises only a single proximal segment and a single
distal segment. The proximal segment and the distal segment in one case are mounted on a single
common stem.
In one ment the stem of the proximal segment and the stem of the distal segment form
parts of the same continuous stem.
68_1 (GHMatters) P42741NZ04
In one embodiment the device comprises a distal marker which is located on the distal side adjacent
to the most distal segment.
In one case the device comprises a proximal marker which is d on the proximal side adjacent
to the most al .
In one embodiment the device comprises at least one further segment between a distal segment
and a proximal segment. There may be a plurality of further segment between a distal segment
and a proximal segment. The connections between at least some of the further segments may
comprise hinges to facilitate relative movement between the further segments.
In one embodiment a proximal end of the device is adapted for releasable connection with a
delivery means such as a delivery wire or tube. There may be a connector for connection to the
delivery wire. The connector may be hingedly le relative to the most proximal segment.
There is further described herein an embolisation device for promoting clot formation in a lumen
comprising at least two segments, each segment sing a stem and a plurality of flexible
bristles ing outwardly from the stem, the bristles having a contracted delivery configuration
and a deployed configuration in which the bristles extend generally radially outwardly from the
stem to anchor the device in a lumen, wherein the device es a flow restrictor having a
contracted delivery configuration and an expanded unrestrained configuration.
In one case the flow restrictor is located adjacent to a al end of the device. The flow
restrictor may be located within or adjacent to the most al t. Alternatively or
additionally the flow restrictor is located nt to the distal end of the device. The flow
restrictor may be located within or adjacent to the most distal t.
In one embodiment the flow restrictor comprises a membrane. The bristles in an unconstrained
configuration may extend to a radial extent which is greater than the radial extent of the membrane
in the unconstrained configuration. In the constrained configuration, the membrane may have a
longitudinal extent. In the deployed configuration, the membrane may have a conical or cup-like
shape.
18517168_1 (GHMatters) P42741NZ04
In one case the flow restrictor may be of a flexible material. The flow restrictor may be of a
polymeric material. The flow restrictor may be of an elastomeric material.
In one embodiment the flow restrictor comprises a film. The flow ctor may comprise a shape
memory material such as Nitinol.
There is further bed herein an embolisation device for promoting clot formation in a lumen
comprising at least two segments, each segment comprising a stem and a plurality of flexible
bristles ing dly from the stem, the bristles having a contracted delivery uration
and a ed configuration in which the bristles extend generally radially outwardly from the
stem to anchor the device in a lumen, comprising a proximal bristle segment and at least one distal
bristle segment, a proximal marker al the most proximal segment, a distal marker distal of
the most distal segment and an ediate marker between the most proximal segment and the
segment which is nt to the most proximal segment.
There is further described herein an embolisation device for ing clot formation in a lumen
comprising at least two segments, each segment comprising a stem and a ity of flexible
bristles which extend radially outwardly of the stem, the bristles having a contracted delivery
configuration and a deployed configuration in which the bristles extend generally radially
outwardly of the stem, the bristles sing distal bristles in a distal bristle segment and
proximal bristles in a proximal segment and wherein there are differences between at least some
of the distal bristles and at least some of the proximal bristles.
In one case the device comprises at least one intermediate segment between the proximal segment
and the distal segment, the intermediate segment comprising intermediate bristles and wherein
there are differences between the intermediate bristles and either or both of the proximal bristles
and the distal es.
In one embodiment the ences comprise a difference in radial extent.
At least some of the bristles in the proximal segment may be tapered proximally or distally.
Alternatively or additionally, at least some of the bristles in the distal segment are tapered
proximally or distally. Alternatively or additionally, the device comprises at least one intermediate
18517168_1 (GHMatters) P42741NZ04
t and at least some of the bristles in the intermediate section are tapered ally or
directly.
In some embodiments at least some adjacent bristle segments are longitudinally spaced-apart.
In one case the differences comprise differences in properties such as ility.
The number of distal bristles may be different from the number of proximal bristles.
In some embodiments at least some of the bristle segments are of non-circular profile in the
deployed configuration.
There is further described herein an embolization device of the invention and a delivery catheter.
In one case the delivery catheter is a microcatheter.
There is further described herein an sation system comprising:-
an embolisation device having a plurality of bristle segments having a contracted delivery
configuration and an expanded deployed configuration;
a connector at a proximal end of the embolisation device;
and a delivery element which is able connected to the connector for delivery of the
embolisation device into the expanded deployed configuration.
The connector may be configured to facilitate movement between the delivery element and the
embolisation device. The connector may be hingedly mounted to the embolisation device.
In one case the system further comprises a ry catheter in which the embolisation device is
retained in the retracted configuration.
There is further described herein an embolization device comprising: a proximal segment; a distal
t; and a flow restricting member, each of the proximal and distal segments including a stem
and a plurality of ing bristles extending dly from the stem.
18517168_1 (GHMatters) P42741NZ04
The flow restrictor may comprise a membrane. The flow restricting membrane may be located on
the proximal segment. The flow restricting membrane may be located on the distal segment.
In one case a flow restricting membrane is located longitudinally within the bristles of the proximal
t and/or the distal segment. The flow restricting membrane may extend from the stem.
The flow restricting membrane may have an outer dimension which is less than an outer dimension
of the plurality of anchoring es. The flow restricting membrane may be connected to the
stem. In some cases the flow restricting membrane may have a central hole. The central hole in
the membrane is preferably smaller than the stem on which it is mounted. The central hole in the
membrane may have a diameter which is smaller than the diameter of the stem.
In one case the l hole adapts its shape and dimension at least in part to the shape and
dimensions of a cross section of the stem. The central hole may be stretched during mounting in
order to fit the stem.
In one case there is an interference fit n the l hole and the stem.
In one case the flow restricting ne is not attached to the ity of bristles.
The flow restricting membrane may be substantially impermeable.
The flow restricting membrane may have a contracted delivery configuration and an expanded
deployed configuration. In the constrained configuration, the flow restricting ne may
have a longitudinal extent. In the deployed configuration the flow restricting membrane may have
a conical or cup-like shape.
The flow restrictor may be of a flexible material. The flow restrictor may be of a polymeric
material. The flow restrictor may be of an elastomeric material. The flow ctor may comprise
a film.
In one case the flow restricting membrane is more flexible than the bristles nt to it.
In one embodiment the distal segment includes more bristles than the proximal segment.
18517168_1 (GHMatters) P42741NZ04
The diameter of the bristles in the distal segment may be greater than the diameter of the bristles
in the proximal segment.
In one case the stem of the proximal segment is mounted to the stem of the distal segment. The
stem of the proximal segment may be substantially rigidly mounted to the stem of the distal
segment.
The embolization device in some cases r comprises at least one radiopaque marker. There
may be a radiopaque marker adjacent to a distal segment and/or a radiopaque marker nt to
the proximal segment and/or a radiopaque marker intermediate the proximal and distal segments.
In one embodiment the device comprises a proximal tor for releasable connection to a
delivery element. The proximal connector may comprise a stem n. The connector stem may
be coupled to the proximal segment stem. The connector stem may be hingedly d to the
proximal segment stem. The connector stem may have a mounting e for engagement with a
mounting feature of a ry element. The connector mounting feature may comprise a screw
thread.
In one embodiment the zation device comprises only a single proximal t and a single
distal segment. The proximal segment and the distal segment in one case are mounted on a single
common stem.
In one embodiment the stem of the al segment and the stem of the distal segment form parts
of the same continuous stem.
The zation device may comprise at least one further segment between the distal segment
and the proximal segment. There may be a plurality of further segment between a distal t
and a proximal segment. The connections between at least some of the further segments may
comprise a hinge to facilitate relative movement between the further segments. The connection
between some of the segments intermediate the proximal segment and the distal segment may be
relatively rigid.
18517168_1 (GHMatters) P42741NZ04
In one case the proximal segment comprises from 40 to 150 bristles, in one case 60 to 150,
optionally 70 to 110, optionally about 90, in another case 50 to 110, optionally 70 to 90, optionally
about 80, in another case 40 to 100, optionally 40 to 75, ally 40 to 60.
In one case the distal segment comprises from 40 to 180 bristles, in one case 70 to 180, optionally
100 to 150, optionally about 125, in another case 50 to 130, optionally 80 to 100, optionally about
90, in another case 40 to 80, optionally 40 to 60.
There is further described herein a method for manufacturing an embolization device comprising
the steps of:-
providing a bristle t having a plurality of bristles extending outwardly of the
stem;
providing a bristle manipulating tool;
manipulating at least some of the bristles so that the bristles are aligned with the
stem;
mounting a flow ctor membrane between the bristles; and
releasing the bristles from the lating tool.
The method may se the step of mounting the membrane on the stem of the bristle segment.
In one case the membrane comprises a central hole which is smaller than the diameter of the bristle
stem and the method comprises engaging the stem in the hole of the membrane.
In one case the central hole adapts its shape and dimension at least in part to the shape and
dimensions of a cross n of the stem. The central hole may be stretched during mounting in
order to fit the stem.
In one case there is an erence fit between the central hole and the stem.
BRIEF DESCRIPTION OF THE DRAWINGS
The invention will be more clearly understood from the following description of an ment
thereof, given by way of example only, with reference to the accompanying drawings, in which:
18517168_1 (GHMatters) P42741NZ04
Fig. 1 is a side view of two connected segments of an embolisation device, in an
unconstrained state, according to the invention;
Fig. 2 is an oblique view of proximal segment of the device of Fig. 1;
Fig. 3 illustrates the collapsed configuration of two segments in a catheter, one ng
distally and the other proximally;
Fig. 4 shows the deployed configuration of a device with a proximally pointing proximal
segment, a membrane, and a distally pointing distal t;
Fig. 5 is a schematic of the flow direction (closed arrows) entering a membrane in the
deployed uration and its effect which facilitates the seal against the vessel wall;
Fig. 6 shows the configuration of two distally pointing segments (proximal and distal
segments) in the collapsed state;
Fig. 7 shows the configuration of two distally pointing ts (proximal and distal
ts) in the deployed state;
Fig. 8 rates an unstable device, with poor co-linearity with the vessel centre line which
may allow flow to pass through;
Fig. 9 shows the dimensions of the device in the undeployed state (a) and the vessel
diameter definition (b);
Fig. 10 illustrates a device with two bristle segments pointing in opposing directions on the
same stem;
Fig. 11 illustrates a device with two bristle segments in ng directions, sharing the
same stem and without a gap in between;
18517168_1 (GHMatters) P42741NZ04
Fig. 12 (a) to (c) illustrates a marking system and the location of s during different
stages of delivery and deployment;
Fig. 13 (a) and (b) shows a tion comprising a thread mechanism utilising a twisted
wire stem as a natural male thread - in this schematic a formed hypotube is used as the
female thread;
Fig. 14 shows a connection comprising a thread mechanism in which a hypotube is attached
to a delivery wire and detachable from the d wire mechanism by a thread mechanism
on the hypotube;
Figs. 15 (a) illustrates an sation device in a fully expanded unrestrained
configuration and (b) in a deployed configuration;
Fig. 15 (c) is an exploded view of an embolization device;
Figs. 16 (a) and (b) are views similar to Fig. 15 of another embolisation device;
Figs. 17 (a) and (b) are views similar to Fig. 15 of a further embolisation device;
Figs. 18 (a) and (b) are views similar to Fig. 15 of a still further embolisation device;
Fig. 19 is a view of a device of the invention in a packaged configuration ready for use;
Fig. 20 is an enlarged view of a g tube of Fig. 19;
Fig. 20 (a) is an ed view of a distal end of another loading tube;
Fig. 21 is an isometric view of an embolisation device according to the invention;
Fig. 22 is an elevational view of an embolisation device of the invention;
Fig. 23 is an isometric view of the device of Fig. 22;
18517168_1 (GHMatters) P42741NZ04
Figs. 24 (a) to (d) illustrate the ry and deployment of the device of Figs. 22 and 23;
Fig. 25 is an isometric view of a further embolisation device according to the invention;
Figs. 26 (a) and (b) illustrate configurations of another embolisation device;
Fig. 27 is an elevational view of portion of a further embolisation device;
Figs. 28 (a) to (c) illustrate the deployment of an sation ;
Fig. 29 is an enlarged view of n of an embolisation device in a deployed
configuration;
Fig. 30 a to r illustrates a range of geometries for embolisation devices according to the
invention;
Figs. 31 illustrate an embolisation device with a low profile;
Figs. 32 illustrate another embolisation device according to the invention;
Figs. 33 illustrate another embolisation device according to the invention;
Fig. 34 illustrates a further embolisation device including a flow blocking member;
Fig. 35 illustrates further embolisation devices according to the invention;
Fig. 36 is a diagram of a two segment embolization device ng an sm;
Fig. 37 is a diagram of a multi segment embolization device bridging a large aneurysm;
Fig. 38 is a diagram of an embolization device;
18517168_1 (GHMatters) P42741NZ04
ED DESCRIPTION
ing to the drawings there is illustrated an embolisation device 1 according to the invention
which comprises a plurality of flexible bristles having ed and contracted urations.
The device comprises a series of segments wherein at least one segment 3 points distally and one
segment 4 points proximally. In some cases there is only a proximal segment 4 and distal segment
The bristles of the proximal segment 4 point proximally and the bristles of the distal t 3
point distally.
A proximally pointing segment is defined as a t in which the bristles point proximally and
the membrane (if present) cone is open at the al end. A distally pointing segment is defined
as a segment in which the bristles point distally and the membrane (if present) cone is open at the
distal end.
At least one segment in this case the proximal segment 3, orates a flow restrictor which in
this case is a thin film flexible membrane 5.
In some cases a series of radiopaque s divides the proximally pointing segment 4 and the
distally pointing segment 3. There may be a proximal marker 6, a distal marker 7 and an
intermediate marker 8.
In one case the embolization device comprises only a single proximal segment 4 and a single
distal segment 3. The proximal segment 4 and the distal segment 3 in one case are mounted on a
single common stem. The stem of the proximal segment 4 and the stem of the distal segment 3
may form parts of the same continuous stem.
In the case where the device comprises more than two segments, the connection between the two
most proximal segments is more stiff than the distal connections. The distal connections generally
comprise a hinge.
In one embodiment, a flexible ne 5 is present in at least one of the segments. The
membrane 5 may comprise a disc of thin film material. The flexibility of the membrane 5 means
18517168_1 (GHMatters) P42741NZ04
its orientation is controlled by the ation of the nt bristles – i.e. if the adjacent bristles
are forced to point distally the membrane 5 will adjust its configuration accordingly. Thus, if the
membrane 5 is deployed from a collapsed condition, such as from within a catheter, the bristles
will cause it to open up to an expanded uration. The membrane 5 may also be placed
proximal or distal to the segment.
In one case, the implant device comprises at least two ts. In one configuration the
membrane 5 is in the most proximal segment. This is shown, in an unconstrained state
schematically in Figs. 1, 2, 21, 22 and 23. In the uration shown the membrane 5 is located
within the proximal segment 4 with bristles both proximal and distal to the membrane 5. In some
cases there may be a distal membrane 5’.
In one case a flow restricting membrane is located longitudinally within the bristles of the proximal
segment and/or the distal segment. The flow restricting membrane may extend from the stem.
The flow restricting membrane may have an outer dimension which is less than an outer ion
of the plurality of anchoring bristles. The flow restricting membrane may be connected to the
stem. In some cases the flow restricting ne may have a central hole that is an interference
fit on the stem. The central hole in the membrane is preferably smaller than the stem on which it
is mounted. The central hole in the membrane may have a diameter which is smaller than the
diameter of the stem.
The implant has a collapsed uration to facilitate delivery through a catheter. By placing the
membrane 5 within the segment 4, i.e. with bristles proximal and distal to it, it is ted from
damage while the implant is being collapsed, or pushed h a catheter. Furthermore, any
friction between the catheter and the membrane 5 is reduced.
In one configuration, the implant is collapsed such that, the bristles of the most proximal segment
4 point proximally, while the bristles of the distal t 3 or segments point distally. Since the
membrane orientation is controlled by the orientation of the bristles, if the membrane 5 is within
the proximal t, it will also point proximally. This is shown schematically in Fig. 3.
18517168_1 (GHMatters) P42741NZ04
Fig. 3 shows a collapsed configuration of two segments 3,4 in a catheter 10, one pointing ly
and the other proximally. It will be noted that the outer periphery of the membrane 5, shown in
the proximal segment 4, is pointing proximally.
When deployed from this configuration, into a vessel a similar but partially expanded
configuration to the collapsed configuration is achieved. This means that the bristles of the
proximal segment 4 point proximally, and the bristles of the distal segment 3 point distally. This
is shown schematically in Fig. 4. In this configuration the t will be anchored from moving
in either direction. This is because the ends of the bristle act in a brake-like fashion increasing
friction between the implant and the wall. On the contrary, if all bristles point distally, the force
ed to push the implant distally will be greater than that required to push the implant
proximally. Thus a device migration may be more likely to occur in the proximal direction.
In one ment the membrane 5, when measured in the unconstrained configuration, has a
diameter which is less than that of the bristle segment, but greater than that of the vessel for which
the device is intended. Thus the membrane is sufficiently large in diameter to contact the
circumference of the vessel. A larger membrane would increase the e of the implant when
in the collapsed ion necessitating a larger catheter for delivery.
As illustrated in Fig. 4 when the device is deployed into a vessel, with a r diameter than the
t, the membrane 5 s a conical or cup-like shape - the open end of the cone proximal
to the closed end. In one configuration the deployed t comprises a membrane 5 with a
conical shape, the open end of the cone proximal to the distal end. In arteries blood from the heart
s the distal arterial tree, that is from proximal to distal. The configuration ensures that the
blood flows into the cone’s volume, i.e. the opening of the cone opposes flow. Thus the blood
will act to expand the cone further enhancing the seal between the ne and the vessel wall
(Fig. 5). In this way occlusion will be facilitated. Thus the greater the force (pressure) of the flow
into the cone, the greater the improvement of the seal against the vessel wall.
Fig. 5 shows a schematic of the flow direction (closed arrows) entering a membrane 5 in the
deployed configuration and its effect on the seal against the vessel wall.
18517168_1 (GHMatters) P42741NZ04
In another embodiment the implant may be sed such that all segments point distally. Fig s.
6 and 7 show the configuration of two distally pointing segments 3,4 (proximal and distal
segments) in the collapsed state. When ed, both the proximal and distal segments will point
distally. Similarly, all segments may be collapsed such that all point proximally. This may be
advantageous when attempting to occlude a lumen in which flow is from distal to proximal, such
as a healthy vein. Figs. 6 and 7 show the uration of two distally pointing segments (proximal
and distal segments) in the collapsed and deployed state.
A different degree of under sizing of the membrane with respect the segment diameter may be
preferable for devices intended for es and veins. For example veins are known to distend
more than arteries during manoeuvres such as Valsalva. Typically arteries distend by 5 to 15%
while veins can distend 20-60%.
To ensure an te seal between the membrane 5 and the vessel wall it is preferable that the
segment centreline is co-linear with that of the vessel. Use of at least two segments in the device
pointing in opposite directions helps to remedy this problem, i.e. the bristles of the proximal
segment pointing proximally, and the bristles of the distal segment pointing distally. This
facilitates a uniform seal of the cone against the vessel wall about its circumference. As can be
seen in Fig. 8, if the t is not co-linear with the vessel, the ne may be unstable. This
instability may enable flow to open or alter the ne geometry from a cone-like shape (for
example by flipping the direction of the cone). Fig. 8 illustrates an unstable device, with poor colinearity
with the vessel centre line which may allow flow to pass through.
The device may include es to improve co-linearity of the device with the vessel centreline.
In one embodiment, the diameter of the segment is significantly larger than that of the target vessel.
This improves the stability of the device within the vessel facilitating co-linearity of the t
and the vessel centreline. Thus the implant is significantly oversized compared to the target vessel.
Preferable dimensions are outlined in Table 1 and Table 2 for s deliverable through 0.0385
to 0.041 inch (0.9779mm to 1.0414mm) and 0.056-0.056 inch 4-1.4224mm) inner diameter
catheters respectively. The dimensions are shown tically in Fig. 9. Fig. 9 shows the
dimensions of the device in the undeployed state (a) and the vessel diameter definition (b).
18517168_1 (GHMatters) P42741NZ04
The oversizing (calculated as the percentage difference in diameter n segment diameter and
the vessel diameter) is preferably at least 20%, more preferably 50% of the vessel diameter and
more preferably at least 100% of the vessel diameter in which the device is implanted. For
example for a target vessel which is 6 mm in diameter, the device diameter may be at least 7.6mm,
preferably at least 9mm, more preferably at least 12mm.
To ensure co-linearity in veins, the degree of oversizing may be increased compared to that used
in arteries. This is e veins are known to distend significantly (for example during Valsalva).
In one configuration the minimum over-sizing is 100%.
In one configuration the connection between two segments has some flexibility to enable tracking
through tortuous anatomy or to accommodate vessel movement during waking etc. It is preferable
that the flexibility of this connection is limited so as to ensure good co-linearity of the segment
with the membrane and the vessel ng good vessel occlusion. This prevents the device from
deploying in a buckled configuration as it exits the catheter tip.
In one embodiment, the bristle segments are on the same stem 20 and there is a gap 23 between
the segments 21, 22 as illustrated in Fig. 10. In another embodiment, two segments 24, 25 on two
ent stems may be connected. In one configuration this connection comprises a crimped or
welded hypotube. Fig. 10 shows a device with two bristles segments 21, 22 pointing in opposing
directions on the same stem 20.
In yet another embodiment, the same t may be configured in the collapsed and deployed
configuration so as to have some bristles (and the membrane) pointing ally and some
bristles pointing distally (Fig. 11). Fig. 11 shows a device with two bristle segments 24, 25 in
opposing directions, sharing the same stem and without a gap in between.
In some instances the physician may wish to deploy at least a n of the device and reposition
it if he or she is not satisfied.
In one case the device orates at least one proximally pointing proximal segment, and at least
one distally pointing distal segment. If the physician deploys the device tely and then
wishes to retrieve and redeploy the , the action of retrieving the implant by ing the
18517168_1 (GHMatters) P42741NZ04
guide catheter over it will cause the direction of the proximal segment or segments to flip upon
passing through the catheter tip. Thus if the implant is re-deployed all segments will point distally.
This will cause the ne to be open distally. Thus flow may be able to flow past the outside
of the membrane. It may be preferable to avoid this situation.
To mitigate this, a radiopaque marking system may be utilised to alert the physician of whether
the ally pointing segment or segments have been deployed from the catheter. Thus the
physician can deploy the distally pointing segments, and assess their position without deploying
the proximally pointing segment or segments. If the physician is unhappy with the on of the
ly pointing segments, they may resheath and redeploy them without altering the direction of
the proximally pointing segments.
In one configuration a radiopaque marker, distal marker 7, is present at the most distal point of the
most distal segment. A second , medial marker 8, is present between the distally pointing
segment(s) and proximally pointing segment(s). A third marker, proximal marker 6, is present at
the most proximal point of the proximally facing segment. In this configuration the section
between the distal and medial marker 7,8 defines the distally facing segments which may be
deployed, ved/repositioned without any effect on their ng direction, and the section
between the medial and third proximal 6,8 s the proximally facing segment which should
not be deployed until the physician is happy with position of the device.
The deployment of the device using this marking system is shown schematically in Figs. 12(a) to
(c) which show the marking system and their locations during different stages of delivery and
ment.
In one case, a section of tube of a radiopaque al known as a marker band may be crimped
onto the tion between the segments. In the case in which a hypotube is used to connect the
segments, the marker may be placed on one or both of the stems of the ts before the
hypotube is crimped in place. In another embodiment the marker band may be placed onto the
hypotube connection. In yet another embodiment the radiopaque marker band may be used to
t two adjacent segments. Attachment may be facilitated by crimping or welding, soldering,
use of an adhesive or other means. In another configuration a marker band may be placed on the
stem distal or proximal to the connection between the two segments.
18517168_1 (GHMatters) P42741NZ04
In one embodiment the membrane is made from a thin film of PTFE. In one embodiment the
membrane is made from a thin film mer such as polyurethane. In one case the membrane is
of a plastic polyurethane, such as a poly-ether urethane, for example an aromatic polyether
urethane. In one embodiment the membrane incorporates a small hole at its centre. To facilitate
placement of the membrane on the bristle segment, the adjacent bristles are collapsed by some
means. The ne can then be threaded over the sed bristles into the desired position.
lating the membrane over the collapsed bristles into position may require that the hole is
stretched to a larger diameter. The use of an elastomer which can accommodate larger
deformations without permanently deforming facilitates this step in manufacture facilitates this.
The ability of this material to stretch facilitates placement of the membrane within the segment
during manufacture.
Because a material such as polyurethane is less lubricious than others ensuring that the membrane
is adequately held t the bristles of the segment in the collapsed configuration and cannot be
pulled off during loading and delivery through a catheter.
In one embodiment the membrane is made from thin film Nitinol. In this instance the es are
not required to collapse, expand and support the membrane.
Preferably the membrane has a low stiffness. This ensures that its behaviour is dominated by the
bristles by the adjacent bristles, and that it can easily flex to ensure a good seal at the vessel wall.
rmore a stiff membrane may have channels udinally. r problem with a stiff
membrane is that cannot fold and conform to a low profile when in the collapsed configuration.
Considering the situation where a polymer membrane such as polyurethane is used, the stiffness
of the membrane may be reduced by reducing its thickness to that of thin film. Dimensions for
the membrane are ed in Table 1 and Table 2. The membrane may also be of PTFE, PET, or
Nylon. PTFE is particularly suitable as it will enhance lubricity ng the device to be red
through the catheter without high force.
It is preferable that the device profile when in the collapsed configuration is as low as possible in
order to enable delivery through a small bore catheter. This reduces complications such as
18517168_1 (GHMatters) P42741NZ04
hematoma and infection at the site of luminal access for the catheters. It is also preferable that the
implant be detachable from the delivery wire at the tion of the physician.
In one configuration, the implant has a detachment mechanism on its proximal end. This ensures
that the physician can readjust its position until he or she is happy, remove the device, or detach
the implant at will. For some designs the diameter of the detachment mechanism may exceed that
of the stem, or even fill the majority of the space within catheter or sheath used to deliver the
implant to the target vessel. Accordingly, when in the collapsed state, if the bristles or membrane
overlap the ment mechanism an increased or excessive profile may occur.
Another solution to this problem is to use a low profile detachment mechanism. In one
embodiment, a twisted wire stem may be used wherein the geometry of the d wire naturally
provides a male screw thread as shown in Fig. 13 A female screw thread may then be threaded
onto this male screw thread. In one embodiment the female screw thread mechanism comprises a
formed hypotube in which the threads on the inside of the hypotube intended to mate with the
threads of the twisted wire stem are formed in place. Preferably the pitch of the twisted wire brush
is the pitch of the thread. A relatively low number of threads may be used with success. A minimum
of two female threads is used preferably.
Fig. 13 shows a thread mechanism utilising the twisted wire stem 30 as a natural male thread. In
this schematic a formed hypotube 31 is used as the female .
In another ment the female screw thread is machined or tapped onto the inside of a tube.
In another uration the female screw thread comprises a coil with a pitch to match that of the
male thread providing a reliable screw ment mechanism.
In one embodiment the male screw thread 30 is a section of the twisted wire stem of the most
proximal segment. In a r ment, the female thread or hypotube 31 is attached at its
proximal end to a delivery wire 35. This facilitates delivery and detachment of the bustle segment
through a er. This is illustrated schematically in Fig. 14 which shows a thread mechanism
in which a hypotube 31 is attached to a delivery wire 35 and able from the twisted wire stem
by a thread mechanism. A thread mechanism which does not e the twisted wire stem may
also be utilised.
18517168_1 (GHMatters) P42741NZ04
Referring in particular to Figs. 22 and 23 in one case a flexible section 40 is provided between the
screw detachment ism 41 and the most proximal segment 4 of the implant. In one
embodiment this flexible section 40 is a hinge. This flexible section 40 enables delivery and
detachment of the implant in tortuous anatomies. This flexible section 40 also serves to ensure
that the proximal end of the implant is atraumatic.
In one embodiment the membrane and bristles do not overlap the detachment mechanism. In this
case the detachment mechanism is located a minimum distance from the most proximal point of
the segment such that the es and ne do not, or at least minimally overlap the
detachment mechanism.
A number of potential device configurations are shown in Figs. 15 to 18. In Figs. 15(a) and (b)
there are two segments – one proximal containing the ne 4 and one distal. Marker bands
6,7,8 are oned as described above.
Referring to figs 16(a) and (b) in this case there are additional distal segments 60 and hinge
connections 61 are provided between the distal segments to accommodate movement n the
segments.
Referring to Figs. 17(a) and (b), in this case the most distal segment also includes a membrane 5’
which has an opening which faces ly in the deployed uration. A vely stiff
connection 62 is provided between the most distal segment and the adjacent segment.
Figs. 18(a) and (b) rate a device r to Fig. 17 and again for increased stability when
deployed, there is a relatively stiff connection 62 between the most distal segment and the adjacent
segment. The connection in this case may be reinforced by or provided by a section of hypotube.
Figs, 19 and 20 show the complete device configuration. In the packaged configuration, when
ready for use, the implant is stored within a loading tube 50. This loading tube 50 comprises a
tube with a haemostasis valve 52 and side arm 51 for flushing. The delivery wire 55 is attached
to the proximal end of the implant and passes through the haemostasis valve. The implant can be
pushed from the loading tube 50 into a catheter for delivery to the target site. In one embodiment
18517168_1 (GHMatters) P42741NZ04
the loading tube has a taper at its distal end to enable it to easily fit into the luer of the catheter
used for delivery of the device to the target vessel.
As previously described the implant is pushed from a loader into a er to be pushed to the site
of treatment. An e of the loader is shown in Fig. 20. In one embodiment the g tube
is made from a lubricious material such as PTFE with an outer diameter of imately 2.9mm
and an inner diameter of approximately 1.65mm. This loading tube is compatible with both 0.056-
0.057” (1.4224mm to 1.4478mm) 5F delivery catheters and 0.035”-0.038” (0.889mm to
mm) 4Fr delivery catheters.
In another embodiment the loading tube has a taper at its distal end to enable it to be compatible
with multiple catheters of ing hub geometries used for delivery of the device to the target
vessel. A taper 56 on the loading tube 55 functions by funnelling the bristles 58 of the distal
segment of the implant into a conical shape. On exit from the loader, the bristles funnel to a profile
less than that of the inner diameter of the catheter hub ensuring that the implant can be pushed
freely from the loading tube without snagging. This allows smooth transition across the
tube/catheter interface and within the delivery catheter.
In one preferred embodiment the outer diameter of the loading tube is 2.9mm and the inner
diameter is 1.65mm. The distal taper comprises an inner diameter from 0.8mm – 1.3mm tapered
over a length of 1 – 6 mm.
Various configurations of ts, membranes and connections are illustrated in Figs. 25 to 29.
In some instances, it may be preferable due to space ctions within the delivery catheter, to
incorporate a ent number of bristles within the proximal and distal bristle segment. This
enables he number of bristles which encourage thrombus formation and prevent device migration
to be maximised, while preventing excessive on within the catheter during delivery and
deployment. This is particularly important in the case in which one bristle segment of the implant
incorporates a membrane since the membrane itself will take up space. It is also preferable to
minimise the diameter of the stem to further enable addition of more bristles. The stem wire
preferably has sufficient diameter to ensure that when twisted the bristles are ly held via
18517168_1 (GHMatters) P42741NZ04
plastic deformation of the stem wire. The following tables contain preferable combinations of
materials and dimensions for the implant.
Attribute als
Range Preferably More Preferably
Bristle Any shape memory metal or polymer - Nitinol, Elgiloy,
Material Nitinol
Stem Wire Stainless Steel, Cobalth Chromium, Cobalt Elgiloy, L605 or
Material Platinum, Tantalum um MP35N
Titanium or Nickel
Alloy
Membrane PTFE, PEEK, Polyurethane, Polyether - Polyether urethane
Material urethane, Polyester urethane, 80A
Polycarbonate urethane
Stem Wire - - Annealed
Material
Condition
Table 1
Attribute 0.035-0.040in (0.889-1.016mm) ID er
Preferably ≥ n (0.9652mm)
Implant for short vessel treatment
Range Preferably More Preferably
Length of Implant (cm) 1-20 1-6 1.5-2.5
Suitable Artery Diameter (mm) 2-13 3-10 3-7
le Vein Diameter (mm) 2-10 3-8 3-8
Bristle Diameter (in) 0.002 0.0015- 0.00175
(0.0254 - 0.0018 (0.04445mm)
0.0508mm) (0.0381-
0.04572mm)
Number of Segments 2-15 2-15 2
Number of Bristles in Proximal 50-130 70-90 80
Segment
Length of Proximal Bristle 2.5-4.0 2.9-3.5 3.5
Segment (mm)
Number of Bristles in Distal 60-140 90-110 100
Segment (no. per mm)
Length of Distal Bristle Segment 3.0-5.0 5
(mm) 4.4
Membrane Diameter (mm) 6-14 6-10 8
Membrane thickness (µm) < 25 < 18 8-16
ne Location Proximal al Proximal segment
and distal and distal
segment segment
18517168_1 (GHMatters) P42741NZ04
Stem Wire Diameter (in) 0.004-0.010 0.005-0.008 0.006
(0.1016- (0.127- (0.1524mm)
0.254mm) mm)
Distal and Proximal Segment 7-20 10-18 15
Diameter (mm)
Gap between segments (mm) 0.5-10 2-5 3-4
Direction of fibres in most Proximally Proximally Proximally pointing
proximal segment pointing pointing
Direction of fibres in most distal Distally Distally Distally pointing
segment, or segments pointing pointing
Table 2a
Attribute Implant for Treatment of Short Vessel
Segments
0.054-0.060in (1.3716 – 1.524mm) ID Catheter
Preferably 0.056in (1.4224mm)
Range Preferably More Preferably
Length of Implant (cm) 1-30 1.5-9 2.0-3.5
Suitable Vein Diameter (mm) 2-14 3-13 5-11
Suitable Artery er 3-10 4-9 5-8
Number of Bristle ts 1-30 1-25 2
Number of Bristles in Proximal 60-150 70-110 90
Segment
Length of Proximal e Segment 2-6 4-5 4.10± 0.5mm
Number of Bristles in Distal 70-180 100-150 125
Segment
Length of Distal Bristle t 2-10 5-7 5.75± 0.5mm
Membrane Diameter (mm) 11-20 13-15 14
Membrane thickness (µm) < 25 < 18 810-16
Membrane on Proximal and Proximal al segment
or distal and distal
segment segment
Stem Wire Diameter (in) 0.004-0.010 0.005- 0.006
0.008 (0.1524mm)
18517168_1 (GHMatters) P42741NZ04
(0.1016- (0.127-
0.254mm) 0.2032mm)
Bristle Diameter (in) 0.001-0.0025 0.00175- 0.002
(0.0254- 0.002 (0.0508mm)
0.0635mm) (0.04445-
0.0508mm)
Segment er (mm) 14-38 18-30 25
Gap Between Segments 0.5-10 2-5 3-4
Direction of fibres in most proximal ally Proximally Proximally pointing
t pointing pointing
Direction of fibres in most distal Distally Distally Distally ng
segment, or ts pointing pointing
Table 2b
In some instances it may be preferable to use a much longer device for vessel occlusion. For
example, in the case of l veins, devices from 5cm to 15cm, or even 25cm may be required
to treat the entire vessel length. For such a vessel, a lower bristle diameter may be riate even
in a large vessel (e.g. 10mm er) since the increased number of bristles, due to the increased
length and number of segments, means a sufficient anchor force can be achieved. A reduced bristle
diameter in combination with a larger number of bristles enables a lower force for advancement
through a catheter, and deployment from a catheter. The ing table outlines some preferable
combinations.
Attribute 0.054-0.060in (1.3716-1.524mm) ID Catheter
Preferably 0.056in (1.4224mm)
Range Preferably More Preferably
Length of Implant (cm) 1-30 1.5-9 2.0-3.5
Suitable Vein Diameter (mm) 2-14 3-13 3-12
Number of Bristle Segments 2-30 4-25 2
Number of Bristles in Proximal 60-150 70-110 90
Segment
Length of Proximal Bristle Segment 2-6 4-5 4.5
Number of Bristles in Distal 70-180 100-150 125
Segment
Length of Distal Bristle Segment 2-10 5-7 6.2
Membrane Diameter (mm) 11-20 13-15 14
Membrane thickness (µm) < 25 < 18 8-16
18517168_1 (GHMatters) P42741NZ04
Membrane Location Proximal Proximal and Proximal segment
and distal distal
t segment
Stem Wire Diameter (in) 0.004- 0.005-0.008 0.006
0.010 (0.0127- (0.1524mm)
(0.1016- 0.2032mm)
0.254mm)
Bristle Diameter (in) 0.001- 0.00175- 0.002
0.0025 0.002 (0.0508mm)
(0.0254- (0.04445-
0.0635mm) 0.0508mm)
Segment Diameter (mm) 14-38 18-30 25
Gap Between Segments 0.5-10 2-5 3-4
Direction of fibres in most proximal Proximally Proximally Proximally
segment pointing pointing pointing
Direction of fibres in most distal Distally Distally Distally pointing
segment, or segments ng pointing
Table 3a
Attribute 0.054-0.060in (1.3716-1.524mm) ID Catheter
Preferably 0.056in 4mm)
Implant for long vessel segment treatment
Range Preferably More
Preferably
Length of Implant (cm) 2-30 4-25 10-20
Suitable Vessel Diameter (mm) 2-20 3-15 3-12
Number of e Segments 2-30 4-25 9-22, or
approximately 1
segment per cm
of implant
length
Number of Bristles in Proximal 50-110 70-90 80
Segment
Length of Proximal Bristle 2-6 2.8-4.2 3.5
Segment (mm)
Number of Bristles in Distal 50-130 80-100 90
Segments
Length of Distal Bristle 2.5-5 3.5-4.5 3.9
Segment (mm)
Membrane Location Proximal and Proximal and Proximal
distal segment distal segment segment
Membrane Diameter (mm) 11-20 13-15 14
ne Thickness (µm) < 25 < 18 9-15
Stem Wire er (in) 0.004-0.010 0.008 0.008
(0.1016- - (0.1524-
0.254mm) 0.2032mm) 0.2032mm)
Bristle Diameter (in) 0.001-0.002 - 0.0175
(0.0254- (0.4445mm)
0.0508mm)
Segment er (mm) 14-38 18-30 25
Gap Between Segments (mm) 0.5-10 2-5 3-7
18517168_1 (GHMatters) P42741NZ04
Direction of fibres in most Proximally Proximally Proximally
proximal t pointing pointing pointing
Direction of fibres in most Distally ng ly Distally
distal segment, or segments pointing pointing
Table 3b
ute Implant for long vessel segment treatment
0.054-0.060in (1.3716-1.524mm) ID Catheter
Preferably 0.056in (1.4224mm)
Range Preferably More
Preferably
Length of Implant (cm) 2-30 4-25 5-20
Suitable Vein Diameter (mm) 2-15 3-15 3-112
Suitable Artery Diameter 2-15 4-9 5-7
Number of Bristle Segments 2-30 4-25 9-22, or
approximately 1
t per cm
of implant
length
Number of Bristles in Proximal 50-110 70-90 80
Segment
Length of Proximal Bristle 2-6 2.8-4.2 3.40 ± 0.5mm
Segment (mm)
Number of Bristles in Distal 50-130 80-100 90
Segments
Length of Distal Bristle 2.5-5 3.5-4.5 3.70± 0.5mm
Segment (mm)
Membrane Location Proximal and / Proximal and Proximal
or distal segment distal segment t
Membrane Diameter (mm) 11-20 13-15 14
ne Thickness (µm) < 25 < 18 10-16
Stem Wire Diameter (in) 0.004-0.010 0.005-0.008 0.006-0.008
(0.1016- (0.127- (0.1524-
0.254mm) 0.2032mm) 0.2032mm)
18517168_1 (GHMatters) P42741NZ04
Bristle Diameter (in) 0.002 - 0.0175
(0.0254- (0.4445mm)
0.0508mm)
Segment Diameter (mm) 14-38 18-30 25
Gap Between Proximal 0.5-10 2-7 3-4
Segments (mm)
Gap Between Distal Segments 0.5-10 2-7 6-6.5
Direction of fibres in most Proximally ally Proximally
proximal segment pointing ng pointing
Direction of fibres in most Distally pointing Distally Distally pointing
distal segment, or segments pointing
Table 3c
In some instances, it is not possible to access a target vessel using a standard catheter or sheath
(which usually has an inner diameter of 0.035-0.038 inches (0.889mm - 0.9652mm)). For these
instances a range of catheters have been developed known as microcatheters. These catheters
exhibit excellent flexibility, and have an outer diameter typically less than 3.3 . The internal
diameter of these ers ranges from 0.012 to 0.029 inches (0.3048mm to 0.7366mm). Standard
internal diameters are 0.021, 0.024 and 0.027 inches 4, 0.6096 and 0.6858mm). For
compatibility with such catheters devices of the invention with the following attributes are
preferred.
Attribute 0.021-0.029in (0.5334-0.7366mm) ID
Catheter
ably 0.027in 8mm)
Range Preferably More Preferably
Suitable Vessel Diameter (mm) 1.0-6.0 - 1.5
Bristle Diameter (in) -0.002 0.0007-0.0015 0.001
7-0.0508mm) (0.01778- (0.0254mm)
0.0381mm)
Number of Segments 1-4 1-2 1
Number of Bristles in Segment 0 200-450 300-400
Length of Proximal Bristle 2-10 3.5-9 7
Segment (mm)
Diameter of Proximal End of 2-12 3-7 3
Segment (mm)
Diameter of Distal End of 4-14 4-10 8
Segment (mm)
Stem Wire Diameter (in) 0.003-0.010 0.003-0.006 0.004-0.005
(0.0762-0.254mm) (0.1016-0.127mm)
18517168_1 (GHMatters) P42741NZ04
(0.0762-
0.1524mm)
Stem Diameter (in) 0.005-0.020 0.005-0.015 0.007
(0.127-0.508mm) (0.127- (0.1778mm)
0.381mm)
Gap n segments (mm) None, or 1-5 None, or 1-3 Not Applicable
Direction of fibres in most Proximally pointing Proximally Proximally
proximal segment pointing pointing
Direction of fibres in most distal Distally pointing Distally Distally pointing
segment, or segments ng
Table 4a
ute 0.030 in (0.635-0.762mm) ID Catheter
Preferably ≥0.027in (0.6858mm)
Implant for short vessel treatment
Range Preferably More
Length of Implant (cm) 1.0-2.5 ≤2.0 ≤15
le Artery Diameter 1.5-7 1.5-5 1.5-4.5
Number of Bristle Segments 1-3 - 2
Number of Bristles in Proximal 100-200 115-135 125
Segment
Length of Proximal Bristle 2-5 2.5-3.5 3
Segment (mm)
Number of Bristles in Distal 50-120 70-90 80
Segments
Length of Distal Bristle 2-5 2.5-3.5 3
Segment (mm)
ne Location Proximal and Proximal and al
distal segment distal segment segment
ne Diameter (mm) 3-8 4-6 5
Membrane Thickness (µm) < 25 < 18 9-15
Stem Wire Diameter (in) 0.002-0.006 0.003-0.004 0.004
(0.0508- (0.0762- 6mm)
0.1524mm) 0.1016mm)
Diameter of Bristle in 0.00075-0.002 - 0.001
Proximal Segment (in) (0.01905- (0.0254mm)
0.508mm)
Diameter of Bristle in Distal 0.001-0.002 - 0.0015
Segment (in) (0.0254- (0.0381mm)
0.0508mm)
t Diameter (mm) 6-20 -12 10
Gap Between Segments (mm) 0.5-4 1-2 1
Table 4b
Attribute 0.025-0.030 in (0.635-0.762mm) ID Catheter
Preferably 0.027in (0.6858mm)
18517168_1 (GHMatters) P42741NZ04
Implant for short vessel treatment
Range Preferably More
Preferably
Length of Implant (cm) 5 ≤2.0 ≤1.5
Suitable Artery Diameter 1.5-7 1.5-5 5
Number of Bristle Segments 1-3 - 2
Number of Bristles in Proximal 40-100 40-75 40-60
Segment
Length of Proximal Bristle 2-5 2.5-3.5 2 ± 0.5mm
Segment (mm)
Number of Bristles in Distal 40-80 40-60 40-60
Segments
Length of Distal Bristle 2-5 2.5-3.5 2± 0.5mm
t (mm)
Membrane Location Proximal and/or Proximal and Proximal
distal segment distal segment segment
Membrane Diameter (mm) 3-8 4-7 6
Membrane Thickness (µm) < 25 < 18 7-13
Stem Wire Diameter (in) 0.001-0.005 0.002-0.004 0.003
4- (0.0508- (0.0762mm)
0.127mm) mm)
Diameter of Bristle in 0.00075-0.002 0.001- 0.0015 0.0015
Proximal Segment (in) (0.01905- (0.0254- (0.0381mm)
0.0508mm) 0.0381mm)
Diameter of Bristle in Distal 0.001-0.002 0.001-0.0015 0.0015
Segment (in) (0.0254- (0.254- (0.0381mm)
0.0508mm) 0.0381mm)
Segment Diameter (mm) 6-20 -12 10
Gap Between ts (mm) 0.5-4 1-2 1
Table 4c
A range of geometries, incorporating gaps between segments may be used. In one embodiment a
bristle segment of uniform diameter may be used (Fig. 30 (a)).
18517168_1 (GHMatters) P42741NZ04
A lower profile collapsed configuration can be achieved for delivery through a microcatheter by
using a taper in which the proximal er of the bristle segment is lower than the distal diameter
of the bristle segment. This is shown schematically in Fig. 30 (b). This is able since the
distal bristles do not need to collapse onto any stem distally, while the proximal bristles lie on all
bristles which are t ly.
In order to ensure adequate anchoring of the implant in the vessel to prevent migration, a specific
portion of the bristle segment may be designed such that a minimum degree of oversizing with
respect to the vessel diameter is orated. The degree of taper introduced may be driven by
this. In one configuration the lowest diameter of the e segment is at least that of the target
vessel diameter. For example in Fig. 30 (f), the lower diameter proximal portion of the implant
may be at least that of the target vessel, while the larger diameter may be substantially larger than
the target vessel. In one embodiment the lower diameter portion of the segment may be 2-4 mm,
while the larger diameter portion of the bristle segment may be 4-8 mm. In another embodiment
the diameter of the e segment may be approximately the same as the target vessel.
In another configuration, a double tapered segment may be used (Fig. 30 (c)), or a number of
individual d segments may be used (Fig. 30 (d)).
The use of a gap can further improve the efficiency (increase in the number of bristles) with which
bristles can be placed within a catheter while ining a low profile implant in the collapsed
condition. More fibres ensures better anchor force and increased interference with blood flow
resulting in better thrombogenicity and shorter time to occlusion. Some examples are shown in
Fig. 30 (m-r) and (d). Any combination of these features (gaps and tapers) can further increase the
effectives of the implant in anchoring within the vessel and causing vessel occlusion.
Another means to enable a profile sufficiently low to fit through a microcatheter is the use of
bristles of differing types i.e. with different properties. For example, as illustrated in Fig. 31 a large
number of fibres of a low diameter may be incorporated in one area of a segment to induce rapid
thrombus formation and vessel occlusion. Similarly a lower number of fibres of a higher diameter
may be orated. In one embodiment a group of fibres of diameter 0.0007 inches
68_1 (GHMatters) P42741NZ04
(0.01778mm), and a group of fibres of 0.001 inches (0.0254mm) is used. In another ce a
group of fibres of 0.001(0.0254mm) and 0.0015 inches (0.0381mm) are used.
When the implant is placed into a catheter it is in a collapsed condition. If all bristles of a segment
are sed such that they all point one direction, the bristles will lie on top of one another. This
increases the profile of the segment in the collapsed condition. A longer segment with more bristles
means a larger profile in the collapsed condition. One means to reduce the profile in the collapsed
condition is to collapse some of the fibres such that they point ly, and others such that they
point proximally. This is shown schematically in Fig. 32.
Following deployment the bristle segment may be resheathed. This will force all fibres which
original pointed proximally to be flipped such that they point distally. In one embodiment there is
sufficient space within the microcatheter to enable all bristles to enter the microcatheter. In another
configuration a most distal portion of the segment may not fully enter the microcatheter due to
insufficient space for the bristles i.e. the e is too high when all fibres of the segment point
distally.
In yet another embodiment, the amount and configurations of the bristle segment may be tuned
such that while not all fibres can enter the catheter, due to insufficient space, the bristles which
remain outside the catheter are aligned roughly parallel to the catheter centreline and thus do not
contact the vessel wall. This ensures that if the physician wishes to remove the implant or alter its
position he or she will cause damage or denudation of the vessel wall.
In yet another embodiment, an extendable connection exists between a distal and proximal
t. This will be advantageous particularly where the collapsed profile is too large to be
resheathed due to proximal segment bristles overlapping the distal segment bristles. As the
ian pulls the proximal segment into the catheter and as the distal segment begins to enter the
er causing resistance the able connection will stretch sing or enabling a gap to
emerge between ts. The increase in the gap size can enable the collapse of more or all of
the segments into the catheter. Fig. 35 (a) shows such a configuration with an extendable
connection in the unloaded state. Fig. 35 (b) displays the same configuration in the loaded state
with the extendable tion elongated. Fig. 35 (c) shows the resheathing step wherein the
catheter collapses the proximal segment es. This action also causes an elongation of the
18517168_1 ters) P42741NZ04
extendable connection alleviating the degree of overlap of the proximal bristles onto the distal
bristles. The extendable connection may comprise a spring or c element which can return to
its original length upon unloading. The extendable connection may comprise non-elastic type
element.
Another means to reduce the profile of the bristle segment is to trim the segment such that it has a
non-circular cross section. This is shown tically in Fig. 33. (a) shows a conventional bristle
segment which has not been trimmed. Fig. 33 (b) shows a segment which has been trimmed such
that there is a lower diameter region. In this way the longer fibres will serve to ensure the implant
is well anchored in the vessel, while the shorter fibres will support us formation. Other noncircular
geometries such as a square Fig. 33 (c), triangular or others may be used.
In some implants, a membrane or flow blocking member may be incorporated. A number of
configurations are shown schematically in Fig. 34 which deal with the problem of space constraints
within a microcatheter. Since the membrane will contribute significantly to the profile of the
implant in the collapsed configuration, it may be advantageous to place the membrane in an area
of the segment which is generally of low profile in the sed configuration. This low profile
area of the segment may be ed by any of the means bed above (including reduced
segment diameter, use of lower er es, use of tapers and the like).
As described previously, the t may be detached via a screw mechanism. In one embodiment
the female or male portion of the detachment mechanism is comprised of a radiopaque material.
This is to facilitate visibility of detachment during use. In yet r embodiment both female
and male portions of the screw detachment mechanism are radiopaque enabling the physician to
distinctively see the male detach from the female.
In one embodiment a male portion of a screw detachment mechanism is attached to the implant,
and the female to the delivery wire. In another embodiment the female portion of the screw
detachment mechanism is attached to the implant and the male n to the delivery wire.
A gap between segments as shown in Fig 9(a) can facilitate a low profile during delivery and
retrieval. During retrieval, via re-sheathing of the implant into a catheter, the gap facilitates a low
profile when the fibres of the proximal segment which may include a membrane are altered from
18517168_1 (GHMatters) P42741NZ04
a proximally ng configuration to a distally pointing direction. In a situation wherein retrieval
of the t is not a desirable attribute the gap between the segments may be as low as 1 mm. In
r embodiment there may be no gap between the distally and proximal segments.
A further embodiment of the device, deliverable through a microcatheter, is described in Table 5.
The design is similar to that shown in Fig. 24. In one configuration a larger e diameter is used
in the distal segment than the proximal segment. This is to ensure maximum outward radial force
from the distal segment helping to anchor the device. A lower bristle diameter may be utilised in
the proximal segment in order to facilitate a membrane in the proximal segment while also being
deliverable through a microcatheter.
As discussed previously, the oversizing of the device diameter compared to the vessel (calculated
as the percentage difference in diameter between segment er and the vessel diameter) is
preferably at least 20%, more preferably 50% of the vessel diameter and more preferably at least
100% of the vessel diameter in which the device is implanted. Even more preferably, 150%
oversizing should be employed.
Embolization Procedures
Embolization procedures may be undertaken by a range of physicians, primarily interventional
radiologists, scular surgeons, and entional cardiologists. There are a number of
indications for embolization. Frequently performed procedures, and the associated physician are
ised in the table below.
In embolization in general the flow direction is from proximal to the distal ade, or away
from the heart). This is the natural flow direction in arteries. In healthy veins, the flow direction
will generally be the opposite grade, towards the heart). However in general, embolization
is performed in patients with reflux meaning flow will also be de.
Because the flow will generally be from proximal to distal it is preferable to have a membrane on
the proximal end of the device open proximally, with the bristles also pointing proximally. This
mitigates any potential for flow to pass around the outside of the membrane.
18517168_1 (GHMatters) P42741NZ04
Indication Primary Target Access Site Direction Notes
Physician Vessel for of Flow
Occlusion
ed Endovascular Accessory Radial Prograde The accessory veins are
Maturation of Surgeon, Veins in Artery draining the venous
Dialysis Access Interventional AVF outflow, therefore flow
Fistulas Radiologist is the opposite of a
normal accessory vein.
Catheter tip points in
direction of flow during
device delivery.
Accessory Venous Prograde The accessory veins are
Veins in Outflow ng the venous
AVF outflow, therefore flow
is the opposite of a
normal accessory vein.
Catheter tip points in
direction of flow during
device ry.
Hemoptysis Interventional Bronchial Femoral / Prograde Catheter tip points in
Radiologist Artery Radial direction of flow during
Artery device delivery
Pre Op Y-90 Interventional Gastroduode Femoral / Prograde Catheter tip points in
(prevent non- Radiologist nal, Gastric, Radial direction of flow during
target Cystic Artery device delivery
embolization) Artery
cele Vascular Gonadal/ Jugular Prograde Refluxing/diseased
n, n Vein / vessel, so flow is away
Interventional Vein Femoral from heart. Catheter tip
Radiologist points in direction of
flow during device
delivery. Membrane
may be used to l
sclerosant to treat
collateral vessels.
18517168_1 (GHMatters) P42741NZ04
Liver Interventional Hepatic Femoral/ Prograde Catheter tip points in
ases Radiologist Artery Radial direction of flow during
Artery device delivery
Type II ar Inferior Femoral/ Prograde Catheter tip points in
Endoleaks Surgeon Mesenteric Radial direction of flow during
Artery, Artery device delivery
Internal Iliac
Arteries
Pelvic Vascular Ovarian r Prograde Refluxing/diseased
Congestion Surgeon, Vein, Vein/ vessel, so flow is away
Syndrome Interventional Internal or Femoral from heart. Catheter tip
Radiologist Pudendal points in ion of
Vein flow during device
delivery. Membrane
may be used to control
sclerosant to treat
collateral vessels.
Hemorrhoids Vascular Internal Iliac Jugular Prograde Refluxing/diseased
Surgeon, or Pudendal Vein/ vessel meaning
entional Vein Femoral rhoidal plexus is
ogist not draining properly.
Flow is away from heart
into the plexus. Catheter
tip points in direction of
flow during device
delivery
Hemorroidal Femoral/ Prograde Catheter tip points in
Arteries Radial direction of flow during
Artery device delivery
Liver Cancer: Interventional Portal Vein Trans- de Catheter tip points in
Promotion of Radiologist hepatic direction of flow during
future remnant entry via device delivery
hypertrophy contralateral
approach
18517168_1 (GHMatters) P42741NZ04
entional Portal Vein Trans- Prograde Depending on
ogist hepatic orientation of
entry via catheter/tip, could be
ipsilateral retrograde flow.
approach
Interventional Portal Vein Jugular Prograde Catheter tip points in
ogist Vein direction of flow during
device delivery
Aneurysms Interventional Splenic, Femoral or Prograde Catheter tip points in
Radiologist hepatic Radial direction of flow during
artery Artery device delivery
Haemorrhage Vascular Any artery Radial or Prograde Catheter tip points in
Surgeon, Femoral direction of flow during
Interventional Artery device delivery
Radiologist
Treatment of an aneurysm with a membrane at distal and proximal ends
Normally blood flows from proximal to distal in the parent vessel, past an aneurysm, with some
filling of the aneurysm sac. It may therefore seem intuitive that occlusion of the proximal inflow
towards the aneurysm should prevent flow into the sac. However, in some scenarios occlusion of
the proximal vessel can alter the namics of the vessels locally, meaning flow can travel
from distal to the aneurysm causing further filling and pressurising of the aneurysm sac. In this
io the physician aims to occlude the parent vessel proximal and distal to the aneurysm. This
is known as front-door backdoor treatment of the sm.
In one embodiment the device may be configured such that there is both a al and distal
membrane on the device, enabling rapid occlusion of the parent vessel both proximal and distal to
the aneurysm. Accordingly the proximal ne is configured to be proximal the aneurysm
sac, while the distal membrane is distal to the membrane sac. In a preferable configuration the
membrane on the proximal bristle segment is open ally, and the membrane on the distal
segment is open distally.
18517168_1 (GHMatters) P42741NZ04
One arrangement with two bristle segments 100, 101 each containing a membrane 102, 103 is
illustrated in Fig. 36. Another arrangement with several additional segments 105 to bridge a larger
aneurysm is illustrated in Fig. 37.
Use of a Stiff and Flexible Interconnects Between Distal Segments in Longer Device
In some instances the properties of the ts may be such that no le connections in
required. For short devices le connections may not be required. However for longer devices
some flexibility may be required. It is preferable that at least one flexible connection per 5cm of
the implant length be present.
In one configuration, a device has many distal bristle segments in which the distal ts are
connected via both flexible and stiff connections. This may be required when flexible connections
between all distal segments mean that the pushability of the t when being delivered through
a catheter is compromised due to too much flexibility. This may be the case in particular where
very flexible connections orating a hinge are used. The replacement of at least one flexible
connection with a stiff or stiffer connection will e the column stiffness of the implant and
hence its pushability. This will reduce the force required to push the implant through the delivery
catheter. It may be able to place the stiff connections intermittently between the flexible
sections to ensure good flexibility along the length while also maintaining good pushability along
the length.
One such device is illustrated in Fig. 38. This device has proximal and distal segment 110, 111
and a plurality of intermediate segments 112. Some of the connections between the segments are
hinged 113 and others are relatively stiff 114.
It is preferable that the membrane is within the bristle segment. A bristle manipulating tool may
be used and some of the bristles may be manipulated so that the bristles are aligned with the stem.
A flow restrictor membrane is mounted n the bristles and fter the bristles are released
from the tool or vice versa.
When the es recover the membrane will be between and protected and secured by bristles
both proximally and distally.
18517168_1 (GHMatters) P42741NZ04
To ensure that the membrane is controlled by the adjacent bristles, some bristles should be t
both distal and proximal to the membrane. In one confirmation the membrane 130 is placed such
that 50% of es are proximal to the membrane while 50% are distal to the membrane. To
prevent overlap of the ne onto structures proximal to the segment (such as a detach
mechanism, or ry wire), the membrane may be placed more distally within the segment. In
one configuration 60% of fibres are proximal to the ne while 40% are distal to the
membrane. In another configuration 70% of fibres are proximal to the membrane while 30% are
distal to the membrane. In another configuration 80% of fibres are proximal to the ne
while 20% are distal to the membrane.
Membrane Hole Diameter and erence Fit
Placement of the membrane within the bristle segments ensures that es inhibit the membrane
from translating proximally or distally along the segment while in use or when deployed. The
security of the membrane may be further improved via an interference fit between a hole in the
ne and of the segment stem. To achieve this, the hole in the membrane should be smaller
than the stem of the segment. Once placed onto the stem the mismatch of the diameter of the stem
and the hole in the membrane will cause friction between the two surfaces and an interference fit.
To achieve an interference fit the hole in the membrane should be less the stem diameter.
Preferably the hole er in the membrane should be at least 0.001in (0.0254mm) less than the
diameter of the stem. More preferably the hole diameter in the membrane should be at least
0.002in (0.508mm) less than the diameter of the stem.
It will be appreciated that if the hole in the membrane is too small, excessive stretching may be
required to apply the membrane to the segment causing irrecoverable deformation of the hole such
that no interference may be present or a gap could exist between the stem and the hole in the
membrane. In this instance some flow may pass h this gap inhibiting the device
performance in terms of occlusion. The hole of the membrane should be no more than 40% less
than the diameter of the stem.
Ideally the hole diameter is specified such that the ratio between the initial hole diameter and
stretched hole diameter should be less than the ultimate elongation of the membrane material such
18517168_1 (GHMatters) P42741NZ04
that the membrane hole diameter will recover to its lower diameter causing interference fit with
the stem.
The device disclosed may also be used in fields beyond embolization. For example, these
embodiments may be particularly useful in the field of contraception wherein the fallopian tubes
are occluded. rmore the device disclosed may be used in the field of bronchiopulmonary
occlusion. For example, in the case where a physician wishes to exclude a portion of the lung by
ing a us.
Modifications and additions can be made to the embodiments of the invention described herein
without ing from the scope of the invention. For example, while the embodiments bed
herein refer to particular es, the invention includes embodiments having different
combinations of features. The invention also includes embodiments that do not include all of the
specific features described.
The invention is not limited to the embodiments hereinbefore described, with reference to the
accompanying drawings, which may be varied in construction and detail.
18517168_1 (GHMatters) P42741NZ04
[Link]
http://www.terumois.com/products/embolics/AZUR.aspx
References
1. Ekeh et al., Complications arising from splenic artery embolisation: a review of an 11-year
experience. The an Journal of Surgery, 205, 250-254, 2013
2. Ryer et al. 2013, ison of es with coils versus vascular plug embolisation of
the internal iliac artery for endovascular aortoiliac aneurysm repair. Journal of Vascular
Surgery, Volume 56, Issue 5, er 2012, Pages 1239–1245.
3. Beddy et al., Testicular varicoceles. Clinical Radiology (2005) 60, 1248–1255
4. Beecroft etal., Percutaneous varicocele embolisation. Canadian Urological Association
l. September 2007, Volume 1, Issue 3
5. Kessel et al., atheter Embolisation and Therapy. Springer ISBN 97884800
0. Published 2010
6. Balian et al. Pelviperineal venous insufficiency and varicose veins of the lower limbs.
Phlebolymphology. 2008; 15(1):17-26.
7. Marsh et al., Coil Protruding into the Common l Vein Following Pelvic Venous
Embolisation. Cardiovascular Interventional Radiology (2008) 31:435–438
8. The Technology of Expansion. Terumo Interventional Systems. Downloaded on February
21, 2013 from http://www.terumois.com/products/embolics/AZUR.aspx
9. Letourneau-Guillon et al., Embolisation of Pulmonary ovenous Malformations with
Amplatzer Vascular Plugs: Safety and Midterm Effectiveness. Journal of ar and
Interventional Radiology, Volume 21, Issue 5, Pages 649-656, May 2010.
. Yoo et al., Preoperative portal vein embolisation using an amplatzer vascular plug.
European Radiology (2009) 19: 1054-1061.
11. Pelage et al. What is Azur Hydrocoil and How Does it Work? Presented at Society of
Interventional Radiology, 2011.
18517168_1 (GHMatters) P42741NZ04
Claims (20)
1. An embolisation device for promoting clot formation in a lumen, sing more than two segments, including at least a proximal segment and a distal segment, each segment 5 sing a stem and a plurality of flexible bristles extending outwardly from the stem, the bristles having a contracted delivery uration and a deployed configuration in which the bristles extend generally radially outwardly from the stem to anchor the device in a lumen; wherein a proximal connection between the proximal segment and a segment adjacent to the proximal segment is relatively stiff.
2. The device as claimed in claim 1, wherein, in the deployed configuration, bristles of one segment extend partially in a first longitudinal direction and the bristles of another segment extend partially in a second longitudinal direction which is opposite to the first longitudinal direction.
3. The device as claimed in claim 1 or 2, wherein the device includes a flow ctor.
4. The device as claimed in claim 3 wherein the flow restrictor comprises a membrane. 20
5. The device as claimed in claim 3 or claim 4, wherein the flow restrictor has a contracted delivery configuration and an expanded deployed uration.
6. The device as claimed in any one of claims 3 to 5, wherein the flow restrictor is located udinally within the bristles of the proximal segment or the distal segment.
7. The device as claimed in any one of the preceding claims, comprising a plurality of r segments between the distal segment and the proximal t.
8. The device as claimed in claim 7, wherein connections between at least some of the further 30 segments comprise a hinge to tate relative movement between the segments.
9. The device as claimed in claim 8, wherein a connection between at least some of the segments intermediate the proximal t and the distal segment is relatively rigid. 35
10. The device as d in any one of the preceding claims, wherein a proximal end of the device is adapted for releasable connection with a delivery means such as a delivery wire or tube. 18517168_1 (GHMatters) P42741NZ04
11. The device as claimed in any one of the preceding claims, r comprising a proximal connector for releasable connection to a delivery element. 5
12. The device as d in claim 11, wherein the proximal connector comprises a connector stem.
13. The device as claimed in claim 12, wherein the connector stem is coupled to the stem of the al segment.
14. The device as claimed in claim 13, wherein the connector stem is hingedly mounted to the stem of the proximal segment.
15. The device as claimed in any of claim 12 to 14, wherein the connector stem has a mounting 15 feature for engagement with a mounting feature of the delivery t.
16. The device as claimed in claim 15, wherein the mounting feature of the connector stem comprises a screw thread. 20
17. The device as claimed in any one of the preceding claims, wherein the proximal connection incorporates or comprises a radiopaque marker such as marker band.
18. The device as d in any one of the preceding claims, further comprising a distal radiopaque marker which is located on a distal side adjacent to a most distal segment.
19. The device as d in any one of the preceding claims, further comprising a proximal radiopaque marker which is located on a al side adjacent to a most proximal marker.
20. The device as claimed in any one of the preceding claims, further comprising a radiopaque 30 marker intermediate the proximal segment and the distal segment. 18517168_1 (GHMatters) P42741NZ04 tnun- Ann-a-::tnu $lnnnnnnuxa
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14184807.7 | 2014-09-15 | ||
EP14184807 | 2014-09-15 | ||
EP15151922.0 | 2015-01-21 | ||
EP15151922 | 2015-01-21 | ||
EP15175292 | 2015-07-03 | ||
EP15175292.0 | 2015-07-03 | ||
NZ755781A NZ755781A (en) | 2014-09-15 | 2015-09-15 | An embolisation device |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ763906A NZ763906A (en) | 2022-03-25 |
NZ763906B2 true NZ763906B2 (en) | 2022-06-28 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020257093B2 (en) | An embolisation device | |
US11571218B2 (en) | Embolisation systems | |
NZ763906B2 (en) | An embolisation device | |
NZ763908B2 (en) | An embolisation device | |
NZ763910B2 (en) | An embolisation device | |
NZ763905B2 (en) | An embolisation device |